These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28643153)

  • 21. The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma.
    Cho J; Kim KM; Kim HC; Lee WY; Kang WK; Park YS; Ha SY
    Pathol Res Pract; 2019 Jan; 215(1):171-176. PubMed ID: 30466765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs.
    Pavlinkova G; Colcher D; Booth BJ; Goel A; Wittel UA; Batra SK
    Int J Cancer; 2001 Dec; 94(5):717-26. PubMed ID: 11745468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
    Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
    Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer.
    Han D; Wu J; Han Y; Wei M; Han S; Lin R; Sun Z; Yang F; Jiao D; Xie P; Zhang L; Yang AG; Zhao A; Wen W; Qin W
    Oncotarget; 2016 Sep; 7(37):59471-59481. PubMed ID: 27448970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
    Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
    J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
    Turner MA; Hollandsworth HM; Nishino H; Amirfakhri S; Lwin TM; Lowy AM; Kaur S; Natarajan G; Mallya K; Hoffman RM; Batra SK; Bouvet M
    In Vivo; 2022; 36(1):57-62. PubMed ID: 34972700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a high affinity TAG-72 binding peptide by phage display selection.
    Xiao N; Cheng D; Wang Y; Chen L; Liu X; Dou S; Liu G; Liang M; Hnatowich DJ; Rusckowski M
    Cancer Biol Ther; 2011 Jan; 11(1):22-31. PubMed ID: 20980835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-hepatoma human single-chain Fv antibody and adriamycin conjugates with potent antitumor activity.
    Chen L; Liu YH; Li YH; Jiang Y; Xie PL; Zhou GH; Li GC
    Int Immunopharmacol; 2014 Jan; 18(1):20-6. PubMed ID: 24239629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
    MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of near infrared fluorescent labeling of monoclonal antibodies as a tool for tissue distribution.
    Conner KP; Rock BM; Kwon GK; Balthasar JP; Abuqayyas L; Wienkers LC; Rock DA
    Drug Metab Dispos; 2014 Nov; 42(11):1906-13. PubMed ID: 25209366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.
    Boogerd LSF; Boonstra MC; Prevoo HAJM; Handgraaf HJM; Kuppen PJK; van de Velde CJH; Fish A; Cordfunke RA; Valentijn ARPM; Terwisscha van Scheltinga AG; MacDonald GC; Cizeau J; Premsukh A; Vinkenburg van Slooten ML; Burggraaf J; Sier CFM; Vahrmeijer AL
    Surg Oncol; 2019 Mar; 28():1-8. PubMed ID: 30851880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer.
    Fung K; Sharma SK; Keinänen O; Roche KL; Lewis JS; Zeglis BM
    Mol Pharm; 2020 Aug; 17(8):3140-3147. PubMed ID: 32644804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
    Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive localization of tumors by immunofluorescence imaging using a single chain Fv fragment of a human monoclonal antibody with broad cancer specificity.
    Ramjiawan B; Maiti P; Aftanas A; Kaplan H; Fast D; Mantsch HH; Jackson M
    Cancer; 2000 Sep; 89(5):1134-44. PubMed ID: 10964344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Peptide NIRF Optical Surgical Navigation Agents for HNSCC.
    Ding H; Kothandaraman S; Gong L; Wright CL; Pan Q; Teknos T; Tweedle MF
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31450798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab
    Polikarpov DM; Campbell DH; McRobb LS; Wu J; Lund ME; Lu Y; Deyev SM; Davidson AS; Walsh BJ; Zvyagin AV; Gillatt DA
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32316186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.